Adelaide Smith, NP
Family · Orlando, FLNPI 1174927370
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.8% of the total across 181 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,840, more than ten times the $106 reported in 2021. Among family clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 181 payments — averaging $29.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$816
- Incyte Corporation$621
- E.r. Squibb & Sons, L.L.C.$490
- Amgen$257
- Sanofi$250
- plus $2K from 17 others
What the payments were for
- Food & beverage$4,97193%
- Education$3857%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 42 | $1,187 |
| Johnson & Johnson | 24 | $816 |
| Incyte Corporation | 23 | $621 |
| E.r. Squibb & Sons, L.L.C. | 18 | $490 |
| Amgen | 7 | $257 |
| Sanofi | 8 | $250 |
| Lilly USA, LLC | 7 | $248 |
| Sun Pharmaceutical Industries Inc. | 8 | $248 |
| Dermavant Sciences, Inc. | 5 | $199 |
| Botanix SB Inc | 5 | $176 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $169 |
| Journey Medical Corporation | 2 | $125 |
| UCB, Inc. | 5 | $115 |
| Arcutis Biotherapeutics, Inc. | 4 | $90 |
| Galderma Laboratories, L.p. | 4 | $65 |
| Novartis | 3 | $58 |
| Regeneron Healthcare Solutions, Inc. | 2 | $56 |
| Verrica Pharmaceuticals Inc. | 2 | $38 |
| Mayne Pharma Commercial LLC | 2 | $38 |
| Pfizer | 2 | $35 |
| Sonendo Inc | 1 | $35 |
| Organon | 1 | $23 |
| Boehringer Ingelheim | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,356 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 61 | $1,349 |
| Fluorouracil | 20 | $1,032 |
| Clobetasol Propionate | 20 | $551 |
| Triamcinolone Acetonide | 60 | $529 |
| Fluocinonide | 19 | $367 |
| Ciclopirox | 11 | $348 |
| Doxycycline Hyclate | 12 | $276 |
| Mupirocin | 19 | $134 |
| Hydrocortisone | 22 | $106 |
| Escitalopram Oxalate | 13 | $12 |
Paid to pharmacies, not to this prescriber.
Other family in Orlando
- Donna OrtizOrlando$417K
- Lindsey McCabeOrlando$37K
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.